Mark Frohlich
@markfrohlich9638
Executive Officer, Promoter
Building Juno Therapeutics, Inc. as Executive Officer, Promoter
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Juno Therapeutics, Inc. was founded in 2013 and has no closure on record.
Named alongside
At BioEclipse Therapeutics, Inc.
- Benjamin CarterExecutive Officer
- Biao HeDirector
- Catherine SohnDirector
- Elona BaumDirector
- Gregory SchiffmanDirector
- Pamela ContagExecutive Officer, Director
- Pamela Reilly ContagExecutive Officer, Director
- STEPHEN THAUExecutive Officer
- Fabio PucciDirector
- Guy DiPierroExecutive Officer
- Laura StoppelDirector
- Lori HuDirector
- Ronald MartellDirector
- Anthony J. EvninDirector
- Bernard J. CassidyExecutive Officer
- Hal J. BarronDirector
- Hans BishopExecutive Officer, Director, Promoter
- Howard J. PienDirector
- Hyam LevitskyExecutive Officer
- Jay J. FlatleyDirector
- Marc J. Tessier-LavigneDirector
Contribution
Mark's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Juno Therapeutics, Inc.Biological Products, (No Diagnostic Substances); filing with the SEC since 2013Executive Officer, Promoter · Biotechnology · SEATTLE, United States · Founded 2013
- BioEclipse Therapeutics, Inc.Director · Biotechnology · SOUTH SAN FRANCISCO, United States
- Indapta Therapeutics Inc.Executive Officer, Director · Other Technology · Houston, United States